NO995711L - Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonister - Google Patents
Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonisterInfo
- Publication number
- NO995711L NO995711L NO995711A NO995711A NO995711L NO 995711 L NO995711 L NO 995711L NO 995711 A NO995711 A NO 995711A NO 995711 A NO995711 A NO 995711A NO 995711 L NO995711 L NO 995711L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- optionally substituted
- group
- compound
- aryl
- Prior art date
Links
- 108010040722 Neurokinin-2 Receptors Proteins 0.000 title 1
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 title 1
- 102100029409 Neuromedin-K receptor Human genes 0.000 title 1
- 102100037342 Substance-K receptor Human genes 0.000 title 1
- LEWDKQKVAFOMPI-UHFFFAOYSA-N quinoline-4-carboxamide Chemical class C1=CC=C2C(C(=O)N)=CC=NC2=C1 LEWDKQKVAFOMPI-UHFFFAOYSA-N 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- -1 cyano, carboxy Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000003107 substituted aryl group Chemical group 0.000 abstract 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- 125000004945 acylaminoalkyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000005518 carboxamido group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000005544 phthalimido group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Forbindelse, eller et solvat eller et salt derav, med formel (I): hvori Ar er en eventuelt substituert aryl eller en Cs-ycykloalkdienylgruppe, eller en C^cyklo-, alkylgruppe eller en eventuelt substituert enkelt eller sammensmeltet ring- aromatisk heterocyklisk gruppe; R er C^alkyl, C3.7cykloalkyl, C3.7cykloalkylalkyl, eventuelt substituert fenyl eller fenyl-Ci.6alkyl, en eventuelt substituert 5-leddet heteroaromatisk ring omfattende opp til fire heteroatomer valgt fra O og N, hydroksy-Ci-ealkyl, amino-C^alkyl, d-ealkylaminoalkyl, di-Ci.6alkylaminoalkyl, Ci.6acylaminoalkyl, d-ealkoksyalkyl, d-ealkylkarbonyl, karboksy, d-ealkoksy- karbonyl, d-ealkoksykarbonyl-d-ealkyl, aminokarbonyl, C^alkylaminokarbonyl, di-d-ealkylaminokarbonyl, halogeno-d-e-alkyl; eller R er en gruppe -(CH2)P-, hvori p er 2 eller 3, og hvilken gruppe danner en ring med et karbonatom av Ar; R, representerer hydrogen eller opp til fire eventuelle substituenter valgt fra listen bestående av: d-ealkyl, Ci.6alkenyl, aryl, Ci.6alkoksy, hydroksy, halogen, nitro, cyano, karboksy, karboksamido, sulfonamido, d-ealkoksykarbonyl, trifluormetyl, acyloksy, ftalimido, amino eller mono- og di-d-ealkylamino; R2 representerer en gruppe -(CH2)n-NY1Y2, hvori n er et helt tall i området fra 1 til 9, Y1 og Y2 uavhengig er valgt fra hydrogen; Ci-ealkyl; C^alkyl substituert med hydroksy, GI. 6alkylamino eller bis-(Ci^alkyl)amino; C^alkenyl; ary! eller aryl-Ci^alkyl, eller YI og Y2 sammen med det nitrogenatom som de er bundet til, representerer en eventuelt substituert N-bundet enkelt eller sammensmeltet ringheterocyklisk gruppe; R3 er forgrenet eller lineær d-ealkyl, CrCycykloalkyl, C^cykloalkylalkyl, eventuelt substituert aryl, eller en eventuelt substituert enkelt eller sammensmeltet ringaromatisk heterocyklisk gruppe; og R4 representerer hydrogen eller Ci^alkyl; en farmasøytisk blanding omfattende en slik forbindelse, fremgangsmåte for frem- stilling av en slik forbindelse og anvendelse av en slik forbindelse i medisinen.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9710750.2A GB9710750D0 (en) | 1997-05-23 | 1997-05-23 | Novel compounds |
| IT002354 IT1295358B1 (it) | 1997-10-17 | 1997-10-17 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
| ITMI972775 IT1296976B1 (it) | 1997-12-16 | 1997-12-16 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
| PCT/EP1998/003014 WO1998052942A1 (en) | 1997-05-23 | 1998-05-18 | Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995711D0 NO995711D0 (no) | 1999-11-22 |
| NO995711L true NO995711L (no) | 2000-01-19 |
Family
ID=27268859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995711A NO995711L (no) | 1997-05-23 | 1999-11-22 | Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonister |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0983262B1 (no) |
| JP (1) | JP2002500645A (no) |
| CN (1) | CN1264378A (no) |
| AP (1) | AP9901695A0 (no) |
| AR (1) | AR012732A1 (no) |
| AT (1) | ATE244711T1 (no) |
| AU (1) | AU8209898A (no) |
| BG (1) | BG104009A (no) |
| BR (1) | BR9809652A (no) |
| CA (1) | CA2291111A1 (no) |
| CO (1) | CO4950515A1 (no) |
| DE (1) | DE69816290T2 (no) |
| DZ (1) | DZ2498A1 (no) |
| EA (1) | EA199901062A1 (no) |
| ES (1) | ES2201509T3 (no) |
| HU (1) | HUP0002300A3 (no) |
| ID (1) | ID22876A (no) |
| IL (1) | IL133036A0 (no) |
| MA (1) | MA26501A1 (no) |
| NO (1) | NO995711L (no) |
| OA (1) | OA11515A (no) |
| PE (1) | PE75199A1 (no) |
| PL (1) | PL336942A1 (no) |
| SK (1) | SK159299A3 (no) |
| TR (1) | TR199902883T2 (no) |
| WO (1) | WO1998052942A1 (no) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR021354A1 (es) * | 1998-11-20 | 2002-07-17 | Smithkline Beecham Spa | Procedimiento para la preparacion de un compuesto derivado de quinolina y un procedimiento para preparar una composicion farmaceutica |
| GB9825554D0 (en) | 1998-11-20 | 1999-01-13 | Smithkline Beecham Spa | Novel Compounds |
| US6780875B2 (en) * | 1998-11-20 | 2004-08-24 | Smithkline Beecham S.P.A. | Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| JP2002540203A (ja) | 1999-03-29 | 2002-11-26 | ニューロゲン コーポレイション | Ｎｋ−３および／またはｇａｂａ（ａ）受容体リガンドとしての４−置換キノリン誘導体 |
| AU4802500A (en) | 1999-04-26 | 2000-11-10 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
| WO2002013825A1 (en) * | 2000-08-11 | 2002-02-21 | Smithkline Beecham P.L.C. | Novel pharmaceutical use of quinnoline derivatives |
| EP1334089A1 (en) * | 2000-11-13 | 2003-08-13 | GlaxoSmithKline S.p.A. | Quinoline derivatives as nk-3 and nk-2 antagonists |
| AU2002226356A1 (en) * | 2000-11-28 | 2002-06-11 | Glaxosmithkline S.P.A. | Quinoline derivatives as nk-3 antagonists |
| GB0028964D0 (en) * | 2000-11-28 | 2001-01-10 | Smithkline Beecham Spa | Novel compounds |
| US6540733B2 (en) | 2000-12-29 | 2003-04-01 | Corazon Technologies, Inc. | Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion |
| WO2002083664A1 (en) * | 2001-04-11 | 2002-10-24 | Glaxosmithkline S.P.A. | 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| GB0109122D0 (en) * | 2001-04-11 | 2001-05-30 | Smithkline Beecham Spa | Novel compounds |
| MY134211A (en) * | 2001-05-18 | 2007-11-30 | Smithkline Beecham Corp | Novel use |
| GB0425077D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| GB0425075D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| GB0425076D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| EP1891012A2 (en) * | 2005-06-03 | 2008-02-27 | AstraZeneca AB | Quinoline derivatives as nk3 anatgonists |
| GB0515580D0 (en) | 2005-07-29 | 2005-09-07 | Merck Sharp & Dohme | Therapeutic compounds |
| AR057130A1 (es) | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
| DE202007017299U1 (de) * | 2007-12-12 | 2009-04-23 | Drebo Werkzeugfabrik Gmbh | Bohrer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK282721B6 (sk) * | 1994-05-27 | 2002-11-06 | Smithkline Beecham S.P.A. | Nepeptidové NK3 antagonistické látky, spôsob ich výroby, farmaceutické prostriedky s ich obsahom a ich použitie |
| AR004735A1 (es) * | 1995-11-24 | 1999-03-10 | Smithkline Beecham Spa | Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento. |
-
1998
- 1998-05-18 CA CA002291111A patent/CA2291111A1/en not_active Abandoned
- 1998-05-18 TR TR1999/02883T patent/TR199902883T2/xx unknown
- 1998-05-18 EA EA199901062A patent/EA199901062A1/ru unknown
- 1998-05-18 DE DE69816290T patent/DE69816290T2/de not_active Expired - Fee Related
- 1998-05-18 HU HU0002300A patent/HUP0002300A3/hu unknown
- 1998-05-18 AU AU82098/98A patent/AU8209898A/en not_active Abandoned
- 1998-05-18 AT AT98932069T patent/ATE244711T1/de not_active IP Right Cessation
- 1998-05-18 ID IDW991432A patent/ID22876A/id unknown
- 1998-05-18 AP APAP/P/1999/001695A patent/AP9901695A0/en unknown
- 1998-05-18 JP JP54996798A patent/JP2002500645A/ja not_active Ceased
- 1998-05-18 SK SK1592-99A patent/SK159299A3/sk unknown
- 1998-05-18 WO PCT/EP1998/003014 patent/WO1998052942A1/en not_active Ceased
- 1998-05-18 BR BR9809652-4A patent/BR9809652A/pt not_active IP Right Cessation
- 1998-05-18 ES ES98932069T patent/ES2201509T3/es not_active Expired - Lifetime
- 1998-05-18 PL PL98336942A patent/PL336942A1/xx unknown
- 1998-05-18 IL IL13303698A patent/IL133036A0/xx unknown
- 1998-05-18 EP EP98932069A patent/EP0983262B1/en not_active Expired - Lifetime
- 1998-05-18 CN CN98807356A patent/CN1264378A/zh active Pending
- 1998-05-19 DZ DZ980108A patent/DZ2498A1/xx active
- 1998-05-20 PE PE1998000398A patent/PE75199A1/es not_active Application Discontinuation
- 1998-05-21 MA MA25086A patent/MA26501A1/fr unknown
- 1998-05-21 AR ARP980102363A patent/AR012732A1/es not_active Application Discontinuation
- 1998-05-22 CO CO98029024A patent/CO4950515A1/es unknown
-
1999
- 1999-11-22 NO NO995711A patent/NO995711L/no not_active Application Discontinuation
- 1999-11-23 OA OA9900253A patent/OA11515A/en unknown
- 1999-12-14 BG BG104009A patent/BG104009A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2291111A1 (en) | 1998-11-26 |
| MA26501A1 (fr) | 2004-12-20 |
| HUP0002300A2 (hu) | 2001-06-28 |
| PE75199A1 (es) | 1999-10-22 |
| OA11515A (en) | 2004-02-04 |
| PL336942A1 (en) | 2000-07-17 |
| EA199901062A1 (ru) | 2000-08-28 |
| AP9901695A0 (en) | 1999-12-31 |
| DE69816290D1 (de) | 2003-08-14 |
| ES2201509T3 (es) | 2004-03-16 |
| HUP0002300A3 (en) | 2002-01-28 |
| CN1264378A (zh) | 2000-08-23 |
| EP0983262B1 (en) | 2003-07-09 |
| BG104009A (en) | 2000-07-31 |
| TR199902883T2 (xx) | 2000-05-22 |
| DE69816290T2 (de) | 2004-05-27 |
| AR012732A1 (es) | 2000-11-08 |
| AU8209898A (en) | 1998-12-11 |
| ATE244711T1 (de) | 2003-07-15 |
| JP2002500645A (ja) | 2002-01-08 |
| BR9809652A (pt) | 2001-09-11 |
| EP0983262A1 (en) | 2000-03-08 |
| DZ2498A1 (fr) | 2003-01-25 |
| SK159299A3 (en) | 2000-06-12 |
| IL133036A0 (en) | 2001-03-19 |
| WO1998052942A1 (en) | 1998-11-26 |
| NO995711D0 (no) | 1999-11-22 |
| ID22876A (id) | 1999-12-16 |
| CO4950515A1 (es) | 2000-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO995711L (no) | Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonister | |
| AP9801238A0 (en) | Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 (NK-3)- and neurokinin 2 (NK-2) receptor antagonists. | |
| HK1041257A1 (zh) | 作為nk-3受體拮抗劑的喹啉-4-酰胺衍生物 | |
| WO2002089800A3 (en) | N-aroyl cyclic amine derivatives as orexin receptor antagonists | |
| AR004972A1 (es) | Compuesto quinolino 4-carboxamidas n-sustituidas, un procedimiento para su preparacion, el uso de los mismos para la fabricacion de un medicamento, una composicion farmaceutica y un antagonista nk-2/nk-3 combinado. | |
| EA200200942A1 (ru) | Фармацевтические композиции, содержащие производные 3-аминоазетидина, новые производные и способ их получения | |
| EA200100428A1 (ru) | Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты) | |
| BG104248A (en) | Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides | |
| EA200602060A1 (ru) | Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы | |
| AR007077A1 (es) | Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento | |
| ES2091615T3 (es) | Derivados de indol fungicidas. | |
| CO5590895A2 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos | |
| NO952208L (no) | Amin-derivater | |
| WO2002034754A3 (en) | Benzoxazinone derivatives, their preparation and use | |
| AR005338A1 (es) | Derivados acetidinalquilicos de heterociclos con nitrogeno n-sustituido o sales farmaceuticamente aceptables de los mismos, un procedimiento paraprepararlos, composiciones farmaceuticas que los comprenden, uso de dichos derivados, sales y composiciones, y compuestos utilizables como intermedios | |
| ATE348813T1 (de) | Chinolinderivate als nk-2 und nk-3 rezeptor- liganden | |
| NO964698D0 (no) | Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase | |
| DK1034174T3 (da) | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer | |
| EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
| AR023111A1 (es) | Derivados de sulfonamida utiles como antagonistas del receptor 5-ht7, un procedimiento para su preparacion y composicion farmaceutica que los comprenden | |
| ATE259359T1 (de) | Benzoxazol-derivate zur verwendung als integrin- inhibitoren | |
| EA200400469A1 (ru) | Замещенные производные алкиламинопиридазинона, способ их получения и содержащие их фармацевтические композиции | |
| MEP12408A (en) | Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors | |
| DK0701551T3 (da) | 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister | |
| ES2186365T3 (es) | Derivados de tetrahidroisoquinolina como moduladores de los receptores d3 de la dopamina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |